Comment
doi: 10.1016/S0140-6736(99)04394-9.
Risk of idiopathic venous thromboembolism in users of progestagens alone
- PMID: 10560680
- DOI: 10.1016/S0140-6736(99)04394-9
Item in Clipboard
Comment
Risk of idiopathic venous thromboembolism in users of progestagens alone
Lancet.
.
Free article
Abstract
Overall, there was a modest, non-significant, positive association between exposure to progestagens alone and venous thromboembolism (VTE). There was no effect with progestagens alone used for contraception, whereas there was a substantial association with the higher dose progestagens used for other reasons.
Comment on
-
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.Lancet. 1995 Dec 16;346(8990):1582-8. Lancet. 1995. PMID: 7500749
-
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.Lancet. 1995 Dec 16;346(8990):1589-93. doi: 10.1016/s0140-6736(95)91928-7. Lancet. 1995. PMID: 7500750
-
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5. Lancet. 1995. PMID: 7500751
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
